Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic syndrome, independently increases the risks of developing cardiovascular disease (CVD) and type 2 diabetes mellitus. Recent emerging evidence suggests that a group of predominantly liver-derived proteins called hepatokines directly affect the progression of atherosclerosis by modulating endothelial dysfunction and infiltration of inflammatory cells into vessel walls. Here, we summarize the role of the representative hepatokines fibroblast growth factor 21, fetuin-A, and selenoprotein P in the progression of CVD.

Citations

Citations to this article as recorded by  

• The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease
  J. Young, K.A. Seeberg, K.M. Aakre, H. Borgeraas, N. Nordstrand, T. Wisløff, J. Hjelmesæth, T. Omland, J.K. Hertel
  Clinical Biochemistry.2024; 123: 110688.     CrossRef
• From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
  Rafael Romero-Becera, Ayelén M. Santamans, Alba C. Arcones, Guadalupe Sabio
  Physiology.2024; 39(2): 98.     CrossRef
• Exerkines and cardiometabolic benefits of exercise: from bench to clinic
  Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
  EMBO Molecular Medicine.2024; 16(3): 432.     CrossRef
• Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography
  Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim
  Diabetes & Metabolism.2024; 50(3): 101534.     CrossRef
• Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective
  Cristina Maria Marginean, Denisa Pirscoveanu, Sergiu Marian Cazacu, Marian Sorin Popescu, Iulia Cristina Marginean, George Alexandru Iacob, Mihaela Popescu
  Gastroenterology Insights.2024; 15(4): 1028.     CrossRef
• Mechanisms underlying the bidirectional association between nonalcoholic fatty liver disease and hypertension
  Hironori Nakagami
  Hypertension Research.2023; 46(2): 539.     CrossRef
• Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
  Zifeng Yang, Ruifeng Tian, Xiao-Jing Zhang, Jingjing Cai, Zhi-Gang She, Hongliang Li
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• “Alphabet” Selenoproteins: Implications in Pathology
  Carmen Beatrice Dogaru, Carmen Duță, Corina Muscurel, Irina Stoian
  International Journal of Molecular Sciences.2023; 24(20): 15344.     CrossRef
• Overview of the Association between Non-Alcoholic Fatty Liver Disease and Hypertension
  Niki S. Kakouri, Costas G. Thomopoulos, Eirini P. Siafi, Angeliki E. Valatsou, Kyriakos S. Dimitriadis, Iliana P. Mani, Sotirios P. Patsilinakos, Dimitrios M. Tousoulis, Konstantinos P. Tsioufis
  Cardiology Discovery.2023;[Epub]     CrossRef
• Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean
  Yun Hwan Oh, Seogsong Jeong, Sun Jae Park, Joseph C Ahn, Sang Min Park
  Medicine.2023; 102(44): e35804.     CrossRef
• Change of cardiovascular risk associated serologic biomarkers after gastric bypass: A comparison of diabetic and non-diabetic Asian patients
  Jih-Hua Wei, Ming-Hsien Lee, Wei-Jei Lee, Shu-Chun Chen, Owaid M. Almalki, Jung-Chien Chen, Chun-Chi Wu, Yi-Chih Lee
  Asian Journal of Surgery.2022; 45(11): 2253.     CrossRef
• The effect of 12 weeks of training in water on serum levels of SIRT1 and FGF-21, glycemic index, and lipid profile in patients with type 2 diabetes
  Bahram Jamali Gharakhanlou, Solmaz Babaei Bonab
  International Journal of Diabetes in Developing Countries.2022; 42(4): 727.     CrossRef
• Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease
  Ji Hye Huh, Kwang Joon Kim, Seung Up Kim, Bong-Soo Cha, Byung-Wan Lee
  Hepatobiliary & Pancreatic Diseases International.2022; 21(3): 241.     CrossRef
• Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk
  Flavien Berthou, Cyril Sobolewski, Daniel Abegg, Margot Fournier, Christine Maeder, Dobrochna Dolicka, Marta Correia de Sousa, Alexander Adibekian, Michelangelo Foti
  International Journal of Molecular Sciences.2022; 23(7): 3959.     CrossRef
• AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C/EBPβ/E3 Ubiquitin Ligase Signaling pathway
  Vishal Kothari, Jeganathan Ramesh Babu, Suresh T. Mathews, Regis Moreau
  PLOS ONE.2022; 17(5): e0266472.     CrossRef
• Modern aspects of pathogenesis of comorbidity of non-alcoholic fatty liver disease and hypertension in the presence or absence of chronic kidney disease.
  K.O. Prosolenko, К.A. Lapshyna, V.V. Ryabuha
  Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini.2022; 2022(1): 55.     CrossRef
• A coagulation factor moonlights in the heart
  Dan Tong, Joseph A. Hill
  Science.2022; 377(6613): 1382.     CrossRef
• Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome
  Karolina Kulik-Kupka, Marzena Jabczyk, Justyna Nowak, Paweł Jagielski, Bartosz Hudzik, Barbara Zubelewicz-Szkodzińska
  Nutrients.2022; 14(19): 4034.     CrossRef
• Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD
  Ruth C. R. Meex, Ellen E. Blaak
  Molecular Nutrition & Food Research.2021;[Epub]     CrossRef
• New Insights Into the Comorbidity of Coronary Heart Disease and Depression
  Yeshun Wu, Bin Zhu, Zijun Chen, Jiahao Duan, Ailin Luo, Ling Yang, Chun Yang
  Current Problems in Cardiology.2021; 46(3): 100413.     CrossRef
• Liver Hepatokines and Peroxisomes As Therapeutic Targets for Cardiovascular Diseases
  Kerui Huang, Hua Bai
  Future Cardiology.2021; 17(4): 535.     CrossRef
• Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine
  Yaxing Zhang, Xian-Ming Fang, Michał Tomczyk
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
  Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, Marica Noviello, Leonilde Bonfrate, David Q.-H. Wang, Piero Portincasa
  International Journal of Molecular Sciences.2021; 22(10): 5375.     CrossRef
• Investigating Fetuin-A and Paraoxonase-1 Activity as Markers in Polycystic Ovary Syndrome Based on Body Mass Index: A Prospective Case-Control Study
  Tugba Gurbuz, Sebnem Alanya Tosun, Aysegul Cebi, Oya Gokmen, Murat Usta
  Cureus.2021;[Epub]     CrossRef
• Extent and features of liver steatosis in vitro pave the way to endothelial dysfunction without physical cell-to-cell contact
  Francesca Baldini, Mohamad Khalil, Nadia Serale, Adriana Voci, Piero Portincasa, Laura Vergani
  Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(12): 3522.     CrossRef
• Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults
  Zhibin Li, Chunmei He, Yongwen Liu, Dongmei Wang, Mingzhu Lin, Changqin Liu, Xiulin Shi, Zheng Chen, Xuejun Li, Shuyu Yang, Weihua Li
  Journal of Atherosclerosis and Thrombosis.2020; 27(5): 418.     CrossRef
• Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome
  Sha Liu, Wenjing Hu, Yirui He, Ling Li, Hua Liu, Lin Gao, Gangyi Yang, Xin Liao
  BMC Endocrine Disorders.2020;[Epub]     CrossRef
• The intrinsic and extrinsic elements regulating inflammation
  M. Mollaei, A. Abbasi, Z.M. Hassan, N. Pakravan
  Life Sciences.2020; 260: 118258.     CrossRef
• A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults
  Jae-Hyung Roh, Jae-Hyeong Park, Hanbyul Lee, Yong-Hoon Yoon, Minsu Kim, Yong-Giun Kim, Gyung-Min Park, Jae-Hwan Lee, In-Whan Seong
  Korean Circulation Journal.2020; 50(8): 695.     CrossRef
• Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity
  Procolo Di Bonito, Lucia Pacifico, Maria Rosaria Licenziati, Claudio Maffeis, Anita Morandi, Melania Manco, Emanuele Miraglia del Giudice, Anna Di Sessa, Giuseppina Campana, Nicola Moio, Marco Giorgio Baroni, Claudio Chiesa, Giovanni De Simone, Giuliana V
  Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(10): 1840.     CrossRef
• Liver governs adipose remodelling via extracellular vesicles in response to lipid overload
  Yue Zhao, Meng-Fei Zhao, Shan Jiang, Jing Wu, Jia Liu, Xian-Wen Yuan, Di Shen, Jing-Zi Zhang, Nan Zhou, Jian He, Lei Fang, Xi-Tai Sun, Bin Xue, Chao-Jun Li
  Nature Communications.2020;[Epub]     CrossRef
• Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
  Nadine Gehrke, Jörn M. Schattenberg
  Gastroenterology.2020; 158(7): 1929.     CrossRef
• Effect of Moderate Aerobic Exercise on Serum Levels of FGF21 and Fetuin A in Women with Type 2 Diabetes
  Exir Vizvari, Parvin farzanegi, Hajar Abbas Zade
  Medical Laboratory Journal.2020; 14(6): 17.     CrossRef
• Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction?
  Niki Katsiki, Christos Mantzoros
  Metabolism.2019; 93: iii.     CrossRef
• Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders
  Willem van den Brink, Jolanda van Bilsen, Kanita Salic, Femke P. M. Hoevenaars, Lars Verschuren, Robert Kleemann, Jildau Bouwman, Gabriele V. Ronnett, Ben van Ommen, Suzan Wopereis
  Frontiers in Nutrition.2019;[Epub]     CrossRef
• Fetuin-A is also an adipokine
  Ishwarlal Jialal, Roma Pahwa
  Lipids in Health and Disease.2019;[Epub]     CrossRef
• Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease
  Xin Su, Yi Kong, Daoquan Peng
  Clinica Chimica Acta.2019; 498: 30.     CrossRef
• Inter-organ cross-talk in metabolic syndrome
  Christina Priest, Peter Tontonoz
  Nature Metabolism.2019; 1(12): 1177.     CrossRef
• The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study
  Ji Cheol Bae, Ji Min Han, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sam Kwon, Sung-Woo Park, Eun Jung Rhee
  Diabetes Research and Clinical Practice.2018; 135: 1.     CrossRef
• Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
  Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher
  Journal of Hepatology.2018; 68(2): 335.     CrossRef
• Frequency and Antibiotic Resistance Pattern of Diarrheagenic Escherichia coli (DEC) Strains Isolated from Children Aged Less Than 10 Years
  Shahram Shahraki Zahedani, Nasrin sayadzai
  Medical Laboratory Journal .2018; 12(2): 7.     CrossRef
• Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation
  Abdelkrim Khadir, Sina Kavalakatt, Dhanya Madhu, Maha Hammad, Sriraman Devarajan, Jaakko Tuomilehto, Ali Tiss
  Lipids in Health and Disease.2018;[Epub]     CrossRef
• Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study
  Kyung Mook Choi, Kyungdo Han, Sanghyun Park, Hye Soo Chung, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Yong Gyu Park, Seon Mee Kim
  Scientific Reports.2018;[Epub]     CrossRef
• Obesity and Male Infertility: Role of Fatty Acids in the Modulation of Sperm Energetic Metabolism
  Alessandra Ferramosca, Mariangela Di Giacomo, Natalina Moscatelli, Vincenzo Zara
  European Journal of Lipid Science and Technology.2018;[Epub]     CrossRef
• The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
  F. Roshanzamir, M. Miraghajani, M. H. Rouhani, M. Mansourian, R. Ghiasvand, S. M. Safavi
  Journal of Endocrinological Investigation.2018; 41(1): 33.     CrossRef
• Clinical and Body Compositional Factors Associated with Metabolic Syndrome in Obese Koreans: A Cross-Sectional Study
  Yoo Mee Kim, Sunghoon Kim, Se Hwa Kim, Young Jun Won
  Metabolic Syndrome and Related Disorders.2018; 16(6): 290.     CrossRef
• Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients
  Yong-ho Lee, Kwang Joon Kim, Myung eun Yoo, Gyuri Kim, Hye-jin Yoon, Kwanhyeong Jo, Jong-Chan Youn, Mijin Yun, Jun Yong Park, Chi Young Shim, Byung-Wan Lee, Seok-Min Kang, Jong-Won Ha, Bong-Soo Cha, Eun Seok Kang
  Journal of Hepatology.2018; 68(4): 764.     CrossRef
• Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?
  Dimitrios Oikonomou, Georgios Georgiopoulos, Vassiliki Katsi, Chris Kourek, Constantinos Tsioufis, Alexendra Alexopoulou, Evaggelia Koutli, Dimitrios Tousoulis
  European Journal of Gastroenterology & Hepatology.2018; 30(9): 979.     CrossRef
• Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
  Ga Eun Nam, Soon Young Hwang, Hye Soo Chung, Ju Hee Choi, Hyun Jung Lee, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
  International Journal of Endocrinology.2018; 2018: 1.     CrossRef
• Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism
  Fen-Yu Tseng, Yen-Ting Chen, Yu-Chiao Chi, Pei-Lung Chen, Wei-Shiung Yang
  Medicine.2018; 97(46): e13254.     CrossRef
• Relationship of Circulating Fetuin-A Levels with Body Size and Metabolic Phenotypes
  Hye Soo Chung, Hyun Jung Lee, Soon Young Hwang, Ju-Hee Choi, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Dong Seop Choi, Sei Hyun Baik, Kyung Mook Choi
  International Journal of Endocrinology.2018; 2018: 1.     CrossRef
• Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
  Yong-ho Lee, Jae Hyeon Kim, So Ra Kim, Heung Yong Jin, Eun-Jung Rhee, Young Min Cho, Byung-Wan Lee
  Journal of Korean Medical Science.2017; 32(1): 60.     CrossRef
• Dietary fatty acids influence sperm quality and function
  A. Ferramosca, N. Moscatelli, M. Di Giacomo, V. Zara
  Andrology.2017; 5(3): 423.     CrossRef
• Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status
  Ji Hye Huh, Kwang Joon Kim, Seung Up Kim, Seung Hwan Han, Kwang-Hyub Han, Bong-Soo Cha, Choon Hee Chung, Byung-Wan Lee
  Metabolism.2017; 66: 23.     CrossRef
• Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
  Ruth C. R. Meex, Matthew J. Watt
  Nature Reviews Endocrinology.2017; 13(9): 509.     CrossRef
• Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
  Hye Jin Yoo, Soon Young Hwang, Ju-Hee Choi, Hyun Jung Lee, Hye Soo Chung, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi, Pavel Strnad
  PLOS ONE.2017; 12(4): e0174717.     CrossRef
• T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders
  Jyoti Rani, Inna Mittal, Atreyi Pramanik, Namita Singh, Namita Dube, Smriti Sharma, Bhanwar Lal Puniya, Muthukurussi Varieth Raghunandanan, Ahmed Mobeen, Srinivasan Ramachandran
  Scientific Reports.2017;[Epub]     CrossRef
• The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study
  Ji Hye Huh, Jang Young Kim, Eunhee Choi, Jae Seok Kim, Yoosoo Chang, Ki-Chul Sung, Tatsuo Shimosawa
  PLOS ONE.2017; 12(7): e0180951.     CrossRef
• A high‐fat diet negatively affects rat sperm mitochondrial respiration
  A. Ferramosca, A. Conte, N. Moscatelli, V. Zara
  Andrology.2016; 4(3): 520.     CrossRef
• The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis
  Kyung Mook Choi
  Endocrinology and Metabolism.2016; 31(1): 1.     CrossRef
• Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
  Young Song, Woo Lee, Yong-ho Lee, Eun Kang, Bong-Soo Cha, Byung-Wan Lee
  International Journal of Molecular Sciences.2016; 17(1): 122.     CrossRef
• Pathogenesis of nonalcoholic steatohepatitis
  Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker
  Cellular and Molecular Life Sciences.2016; 73(10): 1969.     CrossRef
• The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
  You-Cheol Hwang, Won Seon Jeon, Cheol-Young Park, Byung-Soo Youn
  Cardiovascular Diabetology.2016;[Epub]     CrossRef
• Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells
  Ying Hui Li, Dae Hee Choi, Eun Hye Lee, Su Ryeon Seo, Seungkoo Lee, Eun-Hee Cho
  Journal of Biological Chemistry.2016; 291(19): 10277.     CrossRef
• Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice
  Han-Sol Park, Jung Eun Jang, Myoung Seok Ko, Sung Hoon Woo, Bum Joong Kim, Hyun Sik Kim, Hye Sun Park, In-Sun Park, Eun Hee Koh, Ki-Up Lee
  Diabetes & Metabolism Journal.2016; 40(5): 376.     CrossRef
• Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells
  Giuseppe Maulucci, Bareket Daniel, Ofir Cohen, Yossef Avrahami, Shlomo Sasson
  Molecular Aspects of Medicine.2016; 49: 49.     CrossRef
• Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
  Kristina R. Chacko, John Reinus
  Clinics in Liver Disease.2016; 20(2): 387.     CrossRef
• Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
  Gyuri Kim, Yong-ho Lee, Young Min Park, Jungghi Kim, Heesuk Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Dae Jung Kim
  Medicine.2015; 94(27): e1103.     CrossRef
• A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study
  Ji Hye Huh, Song Vogue Ahn, Sang Baek Koh, Eunhee Choi, Jang Young Kim, Ki-Chul Sung, Eung Ju Kim, Jeong Bae Park, Vincent Wong
  PLOS ONE.2015; 10(11): e0143560.     CrossRef
• Endocrine causes of nonalcoholic fatty liver disease
  Laura Marino
  World Journal of Gastroenterology.2015; 21(39): 11053.     CrossRef

Citations

Citations to this article as recorded by  

• Interaction of fetuin-A with obesity related insulin resistance and diabetes mellitus
  Yıldız Öner-İyidoğan, Hikmet Koçak
  Turkish Journal of Biochemistry.2024;[Epub]     CrossRef
• Assessment of serum and salivary visfatin levels in newly diagnosed patients of type-II DM
  Faith R. Jerusha, Vandana Raghunath
  Journal of Oral and Maxillofacial Pathology.2023; 27(4): 663.     CrossRef
• Evaluation of the serum visfatin eotaxin and fetuin-A levels of patients with type 2 diabetes mellitus
  Hacer KAYHAN KAYA, Abdurrahman ŞERMET, Zafer PEKKOLAY, Ezel TAŞDEMİR, Dilek AYGÜN KEŞİM
  Anatolian Current Medical Journal.2022; 4(1): 113.     CrossRef
• The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis
  Š. Sotak, Z. Schroner, I. Lazúrová, M. Felšőci, I. Jochmanová, D. Petrášová, I. Bertková, M. Mitníková, B. Nováková, H. Wagnerová, O. Bobelová
  Physiological Research.2021; (6): 865.     CrossRef
• Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels
  Hatice Kansu-Celik, A. Seval Ozgu-Erdinc, Burcu Kisa, Rahime Bedir Findik, Canan Yilmaz, Yasemin Tasci
  Archives of Endocrinology and Metabolism.2019;[Epub]     CrossRef
• The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
  F. Roshanzamir, M. Miraghajani, M. H. Rouhani, M. Mansourian, R. Ghiasvand, S. M. Safavi
  Journal of Endocrinological Investigation.2018; 41(1): 33.     CrossRef
• Fetuin-A level in type 2 diabetic patients: relation to microvascular complications
  Nehal H. Al-Said, Fatma M. Taha, Ghada M. Abdel-Aziz, Marwa S. Abdel-Tawab
  The Egyptian Journal of Internal Medicine.2018; 30(3): 121.     CrossRef
• Serum levels of fetuin A are increased in women with gestational diabetes mellitus
  Ozlem Turhan Iyidir, Ceyla Konca Degertekin, Banu Aktas Yilmaz, Alev E. Altinova, Fusun B. Toruner, Nuray Bozkurt, Goksun Ayvaz, Mujde Akturk
  Archives of Gynecology and Obstetrics.2015; 291(4): 933.     CrossRef
• Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
  Mia Jüllig, Shelley Yip, Aimin Xu, Greg Smith, Martin Middleditch, Michael Booth, Richard Babor, Grant Beban, Rinki Murphy, Pankaj K. Singh
  PLoS ONE.2014; 9(5): e96489.     CrossRef
• Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome
  Hussein F. Sakr, Fahaid H. Al-Hashem, Waffaa M. Hassab El-Naby, Mahmoud A. Alkhateeb, Mohamed Samir A. Zaki, Hesham M. El Refaey, Mohamed D. Morsy
  Canadian Journal of Physiology and Pharmacology.2014; 92(2): 162.     CrossRef
• Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population – results from the PolSenior substudy
  Magdalena Olszanecka-Glinianowicz, Aleksander Owczarek, Maria Bożentowicz-Wikarek, Aniceta Brzozowska, Małgorzata Mossakowska, Tomasz Zdrojewski, Tomasz Grodzicki, Andrzej Więcek, Jerzy Chudek
  Metabolism.2014; 63(11): 1409.     CrossRef